EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Degrader–Antibody Conjugates: Emerging New Modality

Ki Bum Hong iD, Hongchan An iD

Journal of Medicinal Chemistry · 12.01.2023 · 66 (1) · 140-148

DOI: 10.1021/acs.jmedchem.2c01791 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 29.12.2022. Verfasst von Ki Bum Hong und 1 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro, Dong-gu, 41061 Daegu, Korea. Hauptthemen laut MEDLINE: Immunoconjugates, Antineoplastic Agents. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In order to deliver chemotherapeutics more efficiently, small-molecule-drug conjugates (SMDCs) and antibody-drug conjugates (ADCs) have been synthesized and explored. These conjugates not only provide selective delivery but also improve the therapeutic index of toxins. By merging this conjugate concept with target protein degradation (TPD), the degrader-antibody conjugate (DAC) field has emerged, and clinical trials have even begun in recent years. In this Perspective, we provide the concepts, applications, and recent advances in the area of DACs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesAntineoplastic AgentsPharmaceutical Preparations

Substanzen

ImmunoconjugatesPharmaceutical PreparationsAntineoplastic Agents

Autor:innen und Institutionen

  • New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro, Dong-gu, 41061 Daegu, Korea.

ORCID-Profile: Ki Bum Hong, Hongchan An

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Hong, K. B., & An, H. (2023). Degrader–Antibody Conjugates: Emerging New Modality. Journal of Medicinal Chemistry, 66(1), 140-148. https://doi.org/10.1021/acs.jmedchem.2c01791

Vancouver

Hong KB, An H. Degrader–Antibody Conjugates: Emerging New Modality. Journal of Medicinal Chemistry. 2023;66(1):140-148. doi:10.1021/acs.jmedchem.2c01791

BibTeX
@article{Hong2023,
  author = {Hong, Ki Bum and An, Hongchan},
  title = {Degrader–Antibody Conjugates: Emerging New Modality},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {1},
  pages = {140--148},
  doi = {10.1021/acs.jmedchem.2c01791}
}
Kostenlos starten →